University Clinic Erlangen

Erlangen D-91054

1 studies enrolling now · 4 studies all time

What they study most

Cardiovascular Diseases, Hypertension, Indolent Systemic Mastocytosis, Smoldering Systemic Mastocytosis, Urothelial Carcinoma, Vascular Diseases

Studies at this site

• (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis — Recruiting now
• A Study of the ReCor Medical Paradise System in Clinical Hypertension — Running, not enrolling
• The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension — Running, not enrolling
• Derazantinib and Atezolizumab in Patients With Urothelial Cancer — Completed